{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:26:52Z","timestamp":1794072412288,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"A*STAR Research Entities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jcyt.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:49:55Z","timestamp":1737604195000},"page":"633-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem\/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers"],"prefix":"10.1016","volume":"27","author":[{"given":"Nisha Suyien","family":"Chandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monil Nagad","family":"Bhupendrabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-9953","authenticated-orcid":false,"given":"Thong Teck","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-9482","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-3297","authenticated-orcid":false,"given":"Sai Kiang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9648-0755","authenticated-orcid":false,"given":"Andre Boon Hwa","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-8535","authenticated-orcid":false,"given":"Ruenn Chai","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2025.01.007_bib0001","series-title":"Psoriasis Statistics","author":"Foundation","year":"2020"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.007_bib0002","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.jcyt.2025.01.007_bib0003","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jcyt.2025.01.007_bib0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.ASW.0000550592.08674.43","article-title":"Diagnosis and management of cutaneous psoriasis: a review","volume":"32","author":"Brandon","year":"2019","journal-title":"Adv Skin Wound Care"},{"issue":"4","key":"10.1016\/j.jcyt.2025.01.007_bib0005","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can Fam Physician"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.007_bib0006","first-page":"369","article-title":"Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up","volume":"10","author":"Malatjalian","year":"1996","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.01.007_bib0007","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.1996.tb03885.x","article-title":"Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study","volume":"135","author":"Mahrle","year":"1996","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jcyt.2025.01.007_bib0008","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14712598.2018.1450385","article-title":"The comparative immunogenicity of biologic therapy and its clinical relevance in psoriatic arthritis: a systematic review of the literature","volume":"18","author":"Balsa","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.01.007_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2014.295","article-title":"Immunogenicity of biotherapy used in psoriasis: the science behind the scenes","volume":"135","author":"Jullien","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.007_bib0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.jcyt.2025.01.007_bib0011","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115203","article-title":"Extracellular vesicles are key players in mesenchymal stem cells\u2019 dual potential to regenerate and modulate the immune system","volume":"207","author":"van Griensven","year":"2024","journal-title":"Adv Drug Del Rev"},{"issue":"2","key":"10.1016\/j.jcyt.2025.01.007_bib0013","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/ijms22020720","article-title":"Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation","volume":"22","author":"Zhang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2025.01.007_bib0014","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1038\/srep31119","article-title":"Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0015","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v2i0.22614","article-title":"Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane","volume":"2","author":"Tan","year":"2013","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"10.1016\/j.jcyt.2025.01.007_bib0016","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0017","series-title":"Mesenchymal Stem Cell Therapy","first-page":"39","article-title":"Mesenchymal stem cell exosomes: the future MSC-based therapy?","author":"Lai","year":"2013"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/971907","article-title":"Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome","volume":"2012","author":"Lai","year":"2012","journal-title":"Int J Proteomics"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0019","doi-asserted-by":"crossref","first-page":"29828","DOI":"10.3402\/jev.v5.29828","article-title":"MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA","volume":"5","author":"Lai","year":"2016","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"10.1016\/j.jcyt.2025.01.007_bib0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.yjmcc.2009.12.021","article-title":"Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles","volume":"48","author":"Lai","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"10.1016\/j.jcyt.2025.01.007_bib0021","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1074\/mcp.M600393-MCP200","article-title":"Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells","volume":"6","author":"Sze","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jcyt.2025.01.007_bib0022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-9-47","article-title":"Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs","volume":"9","author":"Chen","year":"2011","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2025.01.007_bib0023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","journal-title":"Dermatology"},{"issue":"23","key":"10.1016\/j.jcyt.2025.01.007_bib0024","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.12998\/wjcc.v9.i23.6798","article-title":"Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report","volume":"9","author":"Ahn","year":"2021","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.jcyt.2025.01.007_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","article-title":"Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study","volume":"7","author":"Cheng","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2025.01.007_bib0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/jir.2021.0146","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate psoriasis-like skin inflammation","volume":"42","author":"Zhang","year":"2022","journal-title":"J Interferon Cytokine Res"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324925000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:34:31Z","timestamp":1777332871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324925000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1465324925000313"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.007","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem\/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}